Summary of WARNER CHILCOTT LTD

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

WCRX > SEC Filings for WCRX > Form 8-K on 17-Mar-2009

All Recent SEC Filings

Show all filings for WARNER CHILCOTT LTD | Request a Trial to NEW EDGAR Online Pro

Form 8-K for WARNER CHILCOTT LTD

17-Mar-2009

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On March 17, 2009, Warner Chilcott Limited (the "Company") issued a press release announcing its receipt of a Paragraph IV Certification Notice from Impax Laboratories, Inc. advising that it has filed an Abbreviated New Drug Application ("ANDA") for a generic version of Doryx 150 mg delayed-release tablets. A copy of the Company's press release is filed as Exhibit 99.1 hereto and is incorporated by reference into this Item 8.01.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

    Exhibit
    Number    Description
    99.1      Press Release issued March 17, 2009 by Warner Chilcott Limited.

Add WCRX to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for WCRX - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.